Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

EFPIA promotes pharma’s contribution to Europe

Launches Pharmafigures website to detail industry investment

- PMLiVE

Merck & Co’s cancer drug Keytruda gaining traction in US

Anti-PD-1 drug is used in around three quarters of eligible patients in US just weeks after FDA approval

- PMLiVE

US investigates Novo Nordisk manufacturing issues

Issues subpoena related to insulin plant in Kalundborg, Denmark

Novartis building

Novartis sells flu vaccines business to CSL for $275m

Follows the Swiss pharma company's asset swap deals with GSK

- PMLiVE

FDA approves Baxter drug for rare form of haemophilia

Obizur is derived from pig proteins

- PMLiVE

Altering genes on demand

New award-winning research techniques could revolutionise drug discovery

- PMLiVE

Orphan drugs lead CHMP recommendations

Clinuvel's Scenesse is first drug set for European approval to treat rare intolerance to sunlight

- PMLiVE

EU boost for GSK’s Ebola vaccine research

And EMA says it' poised to assess possible vaccines or treatments

Celgene building

Celgene signs $1bn immunotherapy deal with Sutro

Includes exclusive option to acquire the San Francisco-based biotech

- PMLiVE

UK landmarks turn pink for breast cancer

Breast Cancer Campaign encourages people to Wear It Pink

A drug bottle with a 'like' option on the label

Facebook: mobile is not a technology, it’s a consumer behaviour

Social network gives pharma marketers attending ThinkDigital some tips

- PMLiVE

Cubist picks Robert Perez as its new CEO

He replaces Michael Bonney who will continue as chair

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links